Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2021  |  Volume : 17  |  Issue : 3  |  Page : 613-618

Chinese expert consensus of image-guided irreversible electroporation for pancreatic cancer


1 Department of Radiology, First Medical Center, Chinese PLA General Hospital, Beijing, China
2 Department of Radiology, Ruijin Hospital/Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 Interventional Medical Center, The Affiliated Hospital of Qingdao University, Qingdao, China
4 Department of Interventional Radiology, Tianjin Medical University General Hospital, Tianjin First Central Hospital, Tianjin, China
5 Department of Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Qingdao, China
6 Department of Radiology, Tianjin Medical University General Hospital, Tianjin First Central Hospital, Tianjin, China
7 Department of Interventional Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
8 Department of Surgery, National Taiwan University, Taipei, Taiwan, China
9 Department of Radiology, First Hospital Affiliated to Army Medical University, Chongqing, China
10 Department of Department of Hepatobiliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
11 Department of Radiology, Tianjin Medical University General Hospital, Tianjin, China
12 Department of Radiology, Henan Cancer Hospital, Zhengzhou, China
13 Department of Radiology, Shandong Medical Imaging Research Institute, Jinan, Shandong, China
14 Department of Interventional Radiology, Hainan Hospital, Chinese PLA General Hospital, Beijing, China
15 Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
16 Department of Interventional and Vascular Surgery, Affiliated Tenth People's Hospital of Tongji University, Interventional Vascular Institute of Tongji University, Shanghai, China
17 Comprehensive Liver Cancer Center, The 5th Medical Center of the PLA General Hospital, Beijing, China
18 Department of Interventional Radiology, First Affiliated Hospital of Soochow University, Suzhou, China
19 Department of Surgical Oncology, Fuda Cancer Hospital, Guang Zhou, Fuda Cancer Hospital, Guangzhou, China
20 Interventional Diagnosis and Treatment Center of Hepatobiliary and Pancreatic Diseases, Affiliated First Hospital, Medical College of Zhejiang University, Zhejiang, China
21 Department of Interventional Vascular Surgery, PLA 252 Hospital, Baoding, China
22 Department of Oncology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
23 Department of Minimally Invasive Intervention, Sun Yat-sen University Cancer Center, Guangzhou, China
24 Ultrasound Medicine, The First Affiliated Hospital of Sun Yat-sen University, Zhengzhou, China
25 Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
26 Department of Interventional Radiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
27 Department of Interventional and Vascular Therapy, The 4th Hospital of Harbin Medical University, Harbin, China
28 Center of Interventional Oncology and Liver Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China
29 Department of Tumor Intervention, Affiliated Renji Hospital, Medical College of Shanghai Jiaotong University, Shanghai, China
30 Department of Interventional Radiology, Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Guangzhou, China
31 Department of Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
32 IR Department of the First Affiliated Hospital of Soochow University, Suzhou, China
33 Department of Ultrasonic Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Harbin, China
34 Department of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China

Correspondence Address:
Xiaokun Hu
Interventional Medical Center, The Affiliated Hospital of Qingdao University, Qingdao
China
Yueyong Xiao
Department of Radiology, First Medical Center of Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing 100853
China
Zhongmin Wang
Department of Radiology, Ruijin Hospital/Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, No. 149, South Chongqing Road, Huangpu District, Shanghai 200020
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jcrt.JCRT_1663_20

Rights and Permissions

Pancreatic cancer (PC) is a lethal disease with extremely high mortality. Although surgical resection is the optimal therapeutic approach for PC, about 30%–40% of those patients are not candidates for surgical resection when diagnosed. Chemotherapy and radiotherapy also could not claim a desirable effect on PC. The application of interventional radiology approaches is limited by unavoidable damage to the surrounding vessels or organs. By the superiority of mechanism and technology, IRE could ablate the tumor by creating irreversible pores on the membrane of PC cells with other tissues like vessels and pancreatic ducts untouched. This consensus gathers the theoretical basis and clinical experience from multiple Chinese medical centers, to provide the application principles and experience from Chinese experts in the IRE field.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1555    
    Printed40    
    Emailed0    
    PDF Downloaded81    
    Comments [Add]    

Recommend this journal